Skip to Content

H 67 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint H 67 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Aurobindo Pharma Limited.

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for H 67

Rivastigmine tartrate 1.5 mg H 67

Rivastigmine Tartrate

Imprint
H 67
Strength
1.5 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0648
Inactive Ingredients
silicon dioxide, hypromellose 2910 (5 mPa.s), magnesium stearate, microcrystalline cellulose, gelatin, ferric oxide red, ferric oxide yellow, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "H 67"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.